Literature DB >> 20733118

Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells.

Chia-Hwa Lee1, Ching-Shui Huang, Ching-Shyang Chen, Shih-Hsin Tu, Ying-Jan Wang, Yu-Jia Chang, Ka-Wai Tam, Po-Li Wei, Tzu-Chun Cheng, Jan-Show Chu, Li-Ching Chen, Chih-Hsiung Wu, Yuan-Soon Ho.   

Abstract

BACKGROUND: Large epidemiological cohort studies in the United States have indicated that active and passive smoking are associated with increased breast cancer risk. However, there was no direct evidence of an effect of tobacco carcinogens on the cellular molecules involved in breast tumorigenesis.
METHODS: Reverse transcription-polymerase chain reaction was used to determine the expression of all of the nicotinic acetylcholine receptor (nAChR) subunits in 50 human breast cancer samples and to determine the expression of the alpha9-nAChR subunit in 276 surgical and laser capture microdissected breast tumor vs normal tissue pairs. Stable MDA-MB-231 breast cancer cell lines were established in which expression of the alpha9-nAChR subunit was inhibited using short interfering RNA. MCF-10A normal human breast epithelial cells were established in which the alpha9-nAChR subunit could be conditionally overexpressed by removal of doxycycline from the culture fluid. Cell proliferation and soft agar assays and tumor growth in nude mice were used as measures of cell transformation. All statistical tests were two-sided.
RESULTS: In 186 (67.3%) of the 276 paired samples, alpha9-nAChR mRNA was expressed at (mean 7.84-fold) higher levels in breast cancers than in surrounding normal tissue. Stable expression of alpha9-nAChR short interfering RNA in MDA-MB-231 cells attenuated nicotine-stimulated proliferation and growth in soft agar and reduced tumor volume when the cells were introduced as xenografts in SCID mice (n = 5 mice per group; mean tumor volume at 6 weeks treatment in mice injected with Si alpha9 cells = 995.6 mm(3), in mice injected with parental cells = 2993.2 mm(3), difference = 1997.6 mm(3), 95% confidence interval [CI] = 1705 to 2290.2 mm(3), P = .009). Long-term treatment of MCF-10A normal breast epithelial cells with either nicotine or its active metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, triggered precancerous transformation as defined by soft agar assay. Inducible overexpression of alpha9-nAChR in MCF-10A cell xenografts in nude mice substantially increased tumor growth (n = 5 mice per group; DOX+, mean tumor volume without nicotine vs with nicotine = 266.2 vs 501.6 mm(3), difference = 235.4 mm(3), 95% CI = 112.7 to 358 mm(3), P = .009; DOX-, mean tumor volume without nicotine vs with nicotine = 621.2 vs 898.6 mm(3), difference = 277.4 mm(3), 95% CI = 98.1 to 456.7 mm(3), P = .016; mean tumor volume in the presence of nicotine, DOX+ vs DOX- = 501.6 vs 898.6 mm(3), difference = 397 mm(3), 95% CI = 241.3 to 552.6 mm(3), P = .009).
CONCLUSION: The alpha9-nAChR is important for nicotine-induced transformation of normal human breast epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20733118     DOI: 10.1093/jnci/djq300

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  59 in total

1.  Association of single nucleotide polymorphisms of nicotinic acetylcholine receptor subunits with cervical neoplasia.

Authors:  Itzel Calleja-Macias; Kathryn Osann; Mariana Remedios-Chan; Hugo A Barrera-Saldana; Berenice Illades-Aguiar; Hoda Anton-Culver; Anna K Chikova; Sergei A Grando; Hans-Ulrich Bernard
Journal:  Life Sci       Date:  2012-03-03       Impact factor: 5.037

2.  Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.

Authors:  Layla Azam; J Michael McIntosh
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

3.  New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer.

Authors:  Anna Chikova; Hans-Ulrich Bernard; Igor B Shchepotin; Sergei A Grando
Journal:  Life Sci       Date:  2012-01-17       Impact factor: 5.037

Review 4.  Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se.

Authors:  Hans-Juergen Haussmann; Marc W Fariss
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

5.  Snus use, smoking and survival among prostate cancer patients.

Authors:  Kathryn M Wilson; Sarah C Markt; Fang Fang; Caroline Nordenvall; Jennifer R Rider; Weimin Ye; Hans-Olov Adami; Pär Stattin; Olof Nyrén; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2016-12-15       Impact factor: 7.396

Review 6.  Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.

Authors:  Dejana Braithwaite; Monika Izano; Dan H Moore; Marilyn L Kwan; Martin C Tammemagi; Robert A Hiatt; Karla Kerlikowske; Candyce H Kroenke; Carol Sweeney; Laurel Habel; Adrienne Castillo; Erin Weltzien; Bette Caan
Journal:  Breast Cancer Res Treat       Date:  2012-09-29       Impact factor: 4.872

7.  Duration-dependent effects of nicotine exposure on growth and AKT activation in human kidney epithelial cells.

Authors:  Yu-Wei Chang; Kamaleshwar P Singh
Journal:  Mol Cell Biochem       Date:  2018-02-02       Impact factor: 3.396

8.  Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population.

Authors:  Ying Wang; Yongjun Zhang; Cuiping Gu; Wenlong Bao; Yejiang Bao
Journal:  Med Oncol       Date:  2014-03-28       Impact factor: 3.064

9.  α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.

Authors:  Vanessa Mucchietto; Francesca Fasoli; Susanna Pucci; Milena Moretti; Roberta Benfante; Annalisa Maroli; Simona Di Lascio; Cristiano Bolchi; Marco Pallavicini; Cheryl Dowell; Michael McIntosh; Francesco Clementi; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-09-08       Impact factor: 8.739

10.  β-Cryptoxanthin Reduced Lung Tumor Multiplicity and Inhibited Lung Cancer Cell Motility by Downregulating Nicotinic Acetylcholine Receptor α7 Signaling.

Authors:  Anita R Iskandar; Benchun Miao; Xinli Li; Kang-Quan Hu; Chun Liu; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.